Free Trial

Marsh & McLennan Companies (NYSE:MRSH) Stock Jumps 6.8% on Strong Earnings

Marsh & McLennan Companies logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Marsh & McLennan shares rose 6.8% after quarterly earnings of $2.03 per share beat the $1.96 consensus estimate. Revenue reached $6.86 billion, up 8.1% year over year.
  • The company declared a quarterly dividend of $0.99 per share, equivalent to an annualized $3.96 payout and a 2.1% yield.
  • Despite the strong results, analyst sentiment remains mixed: the stock carries a consensus “Hold” rating with a $202.75 price target, while some firms maintain Sell or Hold views.
  • MarketBeat previews the top five stocks to own by November 1st.

Shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH - Get Free Report) traded up 6.8% during mid-day trading on Thursday after the company announced better than expected quarterly earnings. The company traded as high as $189.54 and last traded at $190.5710. 808,980 shares traded hands during trading, a decline of 71% from the average session volume of 2,802,236 shares. The stock had previously closed at $178.40.

The financial services provider reported $2.03 earnings per share for the quarter, topping the consensus estimate of $1.96 by $0.07. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The business had revenue of $6.86 billion during the quarter. The company's revenue for the quarter was up 8.1% on a year-over-year basis.

Marsh & McLennan Companies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Thursday, October 1st will be given a $0.99 dividend. The ex-dividend date is Thursday, October 1st. This represents a $3.96 dividend on an annualized basis and a dividend yield of 2.1%. Marsh & McLennan Companies's dividend payout ratio (DPR) is presently 48.41%.

Key Stories Impacting Marsh & McLennan Companies

Here are the key news stories impacting Marsh & McLennan Companies this week:

  • Positive Sentiment: Third-quarter adjusted earnings were $2.03 per share, exceeding the $1.96 consensus estimate and rising from $1.85 a year earlier. The earnings beat suggests solid operating performance and supports the stock’s increase. Marsh Q3 Earnings and Revenues Beat Estimates
  • Positive Sentiment: Revenue reached approximately $6.86 billion, beating expectations by about $220 million and increasing 8.1% year over year. Management also reported 5% underlying revenue growth, reinforcing the view that demand remains healthy across Marsh’s risk, insurance and consulting businesses. Marsh Reports Third Quarter 2026 Results
  • Positive Sentiment: CEO John Doyle said Marsh made significant progress on its Thrive program and completed its brand transition, potentially improving efficiency and strengthening the company’s long-term growth profile. Marsh Reports Third Quarter 2026 Results
  • Neutral Sentiment: RBC Capital maintained its Hold rating, indicating that the quarterly beat was encouraging but not sufficient to change its overall valuation or outlook. RBC Maintains Hold Rating
  • Negative Sentiment: Bank of America Securities continues to rate MRSH Sell, while Wells Fargo and KBW retain Hold ratings. The lack of broad analyst upgrades could temper investor enthusiasm despite the strong results. Bank of America Maintains Sell Rating

Analyst Ratings Changes

A number of equities research analysts have weighed in on MRSH shares. Evercore reduced their target price on Marsh & McLennan Companies from $234.00 to $224.00 in a report on Thursday, October 8th. JPMorgan Chase & Co. boosted their price target on Marsh & McLennan Companies from $212.00 to $215.00 and gave the company an "overweight" rating in a research note on Thursday, October 1st. UBS Group raised their price objective on shares of Marsh & McLennan Companies from $216.00 to $222.00 and gave the stock a "buy" rating in a research report on Tuesday, October 6th. Weiss Ratings upgraded shares of Marsh & McLennan Companies from a "hold (c-)" rating to a "hold (c)" rating in a research report on Friday, August 7th. Finally, BMO Capital Markets decreased their price target on shares of Marsh & McLennan Companies from $203.00 to $179.00 and set a "market perform" rating for the company in a research note on Thursday, October 1st. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, twelve have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Marsh & McLennan Companies currently has an average rating of "Hold" and a consensus price target of $202.75.

Read Our Latest Stock Analysis on Marsh & McLennan Companies

Insider Buying and Selling at Marsh & McLennan Companies

In other news, insider Martin South sold 7,100 shares of the business's stock in a transaction dated Tuesday, July 28th. The shares were sold at an average price of $189.99, for a total transaction of $1,348,929.00. Following the completion of the sale, the insider directly owned 16,632 shares of the company's stock, valued at $3,159,913.68. The trade was a 29.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Lloyd M. Yates sold 12,000 shares of the company's stock in a transaction dated Thursday, July 23rd. The stock was sold at an average price of $175.65, for a total transaction of $2,107,800.00. Following the completion of the sale, the director owned 12,001 shares in the company, valued at $2,107,975.65. This represents a 50.00% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 19,813 shares of company stock worth $3,597,903. 0.38% of the stock is owned by corporate insiders.

Institutional Trading of Marsh & McLennan Companies

Several institutional investors and hedge funds have recently modified their holdings of MRSH. Focus Partners Advisor Solutions LLC bought a new position in Marsh & McLennan Companies during the 2nd quarter valued at approximately $2,153,000. Daiichi Life Insurance Co. Ltd. bought a new stake in shares of Marsh & McLennan Companies in the 2nd quarter worth approximately $3,880,000. Korea Investment CORP bought a new stake in shares of Marsh & McLennan Companies in the 2nd quarter worth approximately $46,856,000. Bank of Nova Scotia purchased a new position in shares of Marsh & McLennan Companies during the second quarter valued at approximately $20,681,000. Finally, Essex LLC purchased a new position in shares of Marsh & McLennan Companies during the first quarter valued at approximately $2,891,000. 87.99% of the stock is owned by hedge funds and other institutional investors.

Marsh & McLennan Companies Stock Up 6.8%

The company's fifty day moving average is $181.35. The firm has a market cap of $90.94 billion, a P/E ratio of 23.35, a P/E/G ratio of 2.46 and a beta of 0.59. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 1.22.

About Marsh & McLennan Companies

(Get Free Report)

Marsh & McLennan Companies, now operating under the name Marsh McLennan, is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through four principal businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman.

Marsh is an insurance brokerage and risk adviser that helps clients identify, manage and transfer risk. Guy Carpenter provides reinsurance brokerage and advisory services to insurance companies.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Marsh & McLennan Companies Right Now?

Before you consider Marsh & McLennan Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.

While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines